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This study concluded that CD38 positive HSC can be 
demonstrated immunohistochemically and the count 
is highly predictive of moderate to severe hepatic 
fibrosis.11 Another study from El-Gendi et al showed that 
CD38 HSC can be observed immunohistochemically in 
human liver core biopsies and the count is predictive 
of degree of hepatic fibrosis.12 Study from Titos et al 
in this journal showed that number of CD38+ HSC is 
associated with degree of fibrosis. Whereas, this study 
also found that there is no correlation between CD38+ 
HSC with inflammation.13 Thus, CD38+ HSC is more 
likely to be a specific marker for liver fibrosis because 
it is not influenced by inflammation.
The used of CD38 is more specific to identify 
HSC and the process of hepatic fibrosis compared to 
alpha-SMA. However, not all active HSC contains 
smooth muscles antigen. CD38 is may be more useful 
in giving information regarding total number of 
active HSC. The more precise immunohistochemical 
features should have advantage in the study of liver 
fibrosis especially the role of HSC.The study of HSC 
is important to understand and eventually may have 
therapeutic implications in the future. 
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Liver injury is a constant thread for the liver because 
it face many substances that enters human body 
through intestine which in most condition can not be 
screened adequately by mechanisms in the digestive 
system. Once the liver injury happened, the liver exerts 
several mechanisms to eliminate the substance and 
or limit the injury such as activate molecular pump 
mechanism in liver cells, activate the Kupffer cells 
and stimulate the activity of stellate cells. 
Hepatic stellate cells (HSC) is the most important 
cells that directly involved in the process of liver injury. 
This cell is actually sit in the middle between sinusoids 
epithelium and liver cell. Any process that trigger the 
mechanism of inflammation also trigger the HSC to 
be active. The most important activity of HSC is in 
the process of fibrosis (fibrogenesis).HSC contribute 
to hepatic inflammation by their ability to secrete and 
respond to a wide range of growth factors.1,2
Immunohistochemical markers for HSC in animal 
liver tissues included desmin and muscle actin (alpha-
SMA).3-6A study form Sandra et al identified cluster 
of differentiation 38 (CD38) as a novel membrane 
molecule of HSC and characterized its expression 
in rat HSC in vitro and in vivo. The study indicated 
that CD38 may be a key regulator of HSC activation 
and effector functions.7 CD38 is a membrane-bound 
protein first identified by monoclonal antibody typing 
of lymphocytes and thus thought of as a lymphocyte-
specific antigen.8 CD38 also known as cyclic ADP 
ribose hydrolase is a glycoprotein found on the 
surface of many immune cells (white blood cells), 
including CD4+, CD8+, B lymphocytes and natural 
killer cells. CD38 also functions in cell adhesion, signal 
transduction and calcium signaling.9
CD38 is also present in many tissues such as brain 
and pancreas other than haematopoetic cells.10 Abdeen 
et al did a study to find out if CD38 can be demonstrated 
immunohistochemically on HSC in liver biopsies from 
patients with chronic hepatitis and to find out if such 
labeling correlated with fibrosis score (METAVIR). 
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